Variations in some biochemical parameters in a group of patients with primary brain tumours: a review of four studies
DOI:
https://doi.org/10.15649/2346075X.457Keywords:
Serum total proteins; serum total cholesterol; serum trace elements; serum pseudouridines; primary brain tumours.Abstract
Introduction: It has been well established and evidence-based fact that serum levels of proteins, cholesterol, trace elements, and
pseudouridines may suffer changes during a neoplastic disease process. This report encompassed four prospective studies, original in Iraq to our knowledge, had explored the serum total proteins (TP), pseudouridines levels, total serum cholesterol (TSC), and serum trace elements (TE), in groups of patients harboring primary brain tumours (PBT) compared to healthy persons. Patients and Methods:Study number 1: A group of 107 patients, from both sexes, aged 2-75 years, harboring PBT were admitted to and operated upon via formal craniotomy by staff neurosurgeons at The Teaching Hospital at Kadhimiyah (TTHK) and Neurosurgical Hospital (NH); their sera were tested for serum total proteins (TP); the latter biochemical parameters were compared with those of 40 healthy persons. Study number II: the same patients and healthy controls were tested for pseudouridine measurement. Study number III: Another group of 30 patients with PBT were studied for TSC levels and were compared with 30 healthy volunteers. Study number IV: A third group of 26 patients with PBT, from both sexes, their sera were tested and measured for TE; the measurements were compared to 1630 volunteers from both sexes and of different age groups. The sera and brain tumor tissue samples were analysed and examined by appropriate methods at relevant laboratories of the TTHK, NH, The Medical Research Centre (MRC) of The College of Medicine, Al-Nahrain University and the Iraqi Atomic Energy Committee (IAEC). Results and Discussion: The serum TP and PBT study: Results are shown in table 1. The serum pseudouridines and PBT study: Mean levels of pseudouridine in serum of PBT patients, were significantly higher (p < 0.01) than its levels in the (normal) controls, table 2. The TSC and PBT study: 1. Hesalthy persons from both sexes: age range, in years, 15 – 75, mean 40.5, SD ± 19.8; TSC range 142 – 230 mg / dl, mean 185.6 mg / dl, SD ± 24.9, (3.7 – 5.9 mmol / l, mean 4.8 mmol / l, SD
± 0.6), table 3. 2. Thirty persons from both sexes having peripheral tumors, with no clinical evidence of brain tumors: age range, in years, 15 – 75, mean 54.3 ± 12.8; TSC range 90 – 220 mg / dl, 143 ± 36.3 (2.3 – 5.7 mmol / l, mean 3.7 ± 0.9), table 4. 3. Thirty patients from both sexes with primary and secondary brain tumors, age range, in years, 15 - 75, mean 41.3 ± 20.9; TSC range 140 – 284 mg / dl, 217.6 ± 41.2 (3.6 – 7.3 mmol / l, 5.6 ±
1.1), table 4. Study number IV: Serum mean values (and S.D.) of all measured TEs were as follow: Se 0.045 +/- 0.011, Zn 0.320 +/- 0.095, Cu 0.607 +/- 0.154, Fe 0.880 +/- 0.456, Mg 13.625 +/- 3.994, Co 0.020 +/- 0.036, Ni 0.016 +/- 0.030, Mn 0.016 +/- 0.009, Cd 0.050 (one sample), and Cr 0.015 +/- 0.005 micrograms per milliliter (mcg / ml). All mean concentrations were consistently lower in the patients than healthy volunteers; both the Student’s (t) and probability (p value) tests were performed; for Se, Zn, Cu, Mg, Co, Ni, Mn, and Cr the p value was <0.01 showing statistically significant results; however, for Fe, though the mean concentration was also lower in the brain tumor group, there was no statistical significance, p > 0.05. Due to technical difficulties and very low concentration of Cd, it was not measured in healthy volunteers; however, it was measured in only one patient’s serum sample; this has been discarded from the study, table 5. Conclusions: Levels of serum TP, TC, and pseudouridine are higher in patients with PBT than in healthy people; however, those of serum TE are lower in the PBT group than healthy persons; the results of this report are in keeping with those of other researchers. The biochemical parameters can be an additional laboratory monitor in the investigation of PBT patients; however, both the specificity and sensitivity need to be ascertained. To our knowledge, this was the first study to be performed in Iraq in the setting of PBT
References
Del Sole A, Falini A, Ravasi L, Ottobrini L, De Marchis D, Bombardieri E, Lucignani G. Anatomical and biochemical investigation of primary brain tumours. Eur-J-Nucl-Med 2001; 28(12): 1851-72. https://doi.org/10.1007/s002590100604
Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J-Neurooncol 2003; 61(2): 151-60. https://doi.org/10.1023/A:1022106910017
Mason JB. Consequences of altered micronutrient status. In: Goldman L, Bennett JC (eds). Cecil Textbook of Medicine, 21st edition. Philadelphia London Toronto Sydney: W. B. Saunders Company 2000: 1170-78.
Herbert PN. Principles of nutritional support in adult patient. In: Anderioli TE (editor-in-chief), Carpenter CCJ, Griggs RC, Loscalzo J (eds.). Cecil Essentials of Medicine, 5th edition. Philadelphia London New York St. Louis Sydney Toronto: W. B. Saunders Company 2001: 522-25.
Fiandra U, Bo M, Fonte G, Poli L, Fabris F. Cancer Detection and Prevention 1993 ; 17 (1) : 1.
Al - Rawi N. Measurment of trace elements, enzymes, and proteins in saliva, serum and tissue extracts in patients with Oral Cancer. A potential tool for diagnosis and prognosis; Ph. D. Thesis, College of Dentistry. Baghdad University 2001.
Kashmoola M. ; Quantitative analysis of Trace elements , Nucleosides , and Immunoglobulins in Saliva of Patients with Oral cancer ; Ph. D. Thesis , College Of Dentistry . Baghdad University 2000.
Nagashima M, Schreiber G. Am Assoc Clin Chem 1984; 1: 1.
Whicher J. Abnormalities of plasma protiens In: Biochemistry in Clinical Practice. Williams D, Marks V (eds). London, William Heinemann 1983. 10. Goldberg D, Brown D. Biochemical tests in the diagnosis, classification, and management of patients with malignant lymphoma and leukemia. Clin Chem Acta 1987; 169:1. https://doi.org/10.1016/0009-8981(87)90394-9
Berry W, Laszlo J, Cox E, Walker A, Paulson D. Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate. Cancer 1979; 44 (2): 763-75. https://doi.org/10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO;2-5
Sirott MN, Bajorin DF, Wong GY, Tao Y, Chapman PB, Templeton MA, Houghton AN. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 1993; 72 (10): 3091-8. https://doi.org/10.1002/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V
Heys S, Walker L, Deehan D, Ermino O. Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg. Edinb 1998; 43 (3): 163-8.
Keating K, Smith T, Gehan E, Merdie K, Bodey G, Freireich E. Prediction of remission in adult acute leukemia: development and testing of predictive models. Cancer 1982; 50: 457. https://doi.org/10.1002/1097-0142(19820801)50:3<457::AID-CNCR2820500313>3.0.CO;2-K
Seaton K.Health, wealth, and hygiene. JNMA 1994; 86 (5): 327.
Deehan D, Heys S, Simpson W, Herriot R, Broom J, Eremin O. Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol 1994; 95 (3): 366-72. https://doi.org/10.1111/j.1365-2249.1994.tb07005.x
Dudek H, Farbiszewski R, Michno T, Lebkowski WJ, Kozlowski A. Activity of glutathione peroxidase, glutathione reductase and superoxide dismutase in the brain tumors. Przegl-Lek 2001; 58(6): 504-6.
Saadoun S, Papadopoulos M C, Davies D C, Bell B A, Krishna S. Increased aquaporin 1 water channel expression in human brain tumours. Br-J-Cancer 2002; 87(6): 621-3. https://doi.org/10.1038/sj.bjc.6600512
Saadoun S, Papadopoulos MC, Davies DC, Krishna S, Bell BA. Aquaporin-4 expression is increased in oedematous human brain tumours. J-Neurol-Neurosurg-Psychiatry 2002; 72(2): 262-5. https://doi.org/10.1136/jnnp.72.2.262
Stockhammer G, Obwegeser A, Kostron H, Schumacher P, Muigg A, Felber S, MaierH, Slavc I, Gunsilius E, Gastl G. Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta-Neuropathol-(Berl) 2000; 100(1): 101-5. https://doi.org/10.1007/s004010051199
Arefyeva IA, Semenova,JB, Zubairaev MS, Kondrasheva EA, Moshkin AV. Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH. Acta-Nurochir-(Wien) 2002; 144(6): 551-4. https://doi.org/10.1007/s007010200077
Salvatore F, Colonna A, Costanzo F, Russo T, Esposito F, and Cimino F. Level of pseudouridine in renal failure patients. Recent Results Cancer Res 1983; 84: 360. https://doi.org/10.1007/978-3-642-81947-6_27
Dlugajczk A, and Eiler J. Elevated of Pseudouridine as indicator of tRNA turnover. Proc Soc Exp Biol Med 1966; 123: 453. https://doi.org/10.3181/00379727-123-31512
Waalkes T, Gehrke C, Kuo K, Lankings D, and Borek E. Pseudouridine effect on Lymphoma and T-acute lymphoma leukemia. J Natl Cancer Inst 1976; 57: 435. https://doi.org/10.1093/jnci/57.2.435
Hamad AWR, Al-Rawi WWH, Al-Bazaz A, and Ameer AA. Determination of Pseudopuridine in Serum and saliva of primary brain Tumour patients by using High Performance Liquid Chromatography. European Journal of Biomedical and Pharmaceutical Sciences 2016; 3 Issue 9: 147-152.
Grieb P, Ryba MS, Jagielski J, Gackowski W, Paczkowski P, Chrapusta SJ. Serum cholesterol in cerebral malignancies. J Neurooncol; 41(2):175-80. https://doi.org/10.1023/A:1006131418126
Simo Camps E, Orti Llaveria A, Sena Ferrer F, Contreras Barbeta E. Blood cholesterol in patients with cancer. An Med Interna ; 15(7):363-6.
Fiorenza AM, Branchi A, Cardena A, Molgora M, Rovellini A, Sommariva D. Serum cholesterol levels in patients with cancer. Relationship with nutritional status. Int J Clin Lab Res; 26(1):37-42. https://doi.org/10.1007/BF02644772
Sorlie PD, Fienleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst; 69(5):989-96.
Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res; 30(3):141-5. https://doi.org/10.1007/s005990070013
Al-Azzawi HJA. Serum lipid profile in apparently healthy Iraqi adults in Baghdad. Citing from many references in this thesis submitted to the Iraqi Commission for Medical Specialization in partial fulfillment of the requirements for the degree of fellowship in Community Medicine, 34-6.
Al-Rawi WWH, Hamad AWR, Muslih RK, Al-Kenany NAM. Serum cholesterol in brain and few other peripheral tumours. Kurdistan Acadimician Journal 2008; 6A, 1.
Al- Rawi WWH, Hamada AJ. Serum cholesterol in brain and few other peripheral tumors: a pilot study at two neurosurgical centers in Baghdad. Kurdistan Acadimician Journal 2008; 6A, 1.
Nygren C, von Holst H, Mansson JE, Fredman P. Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain. Br J Neurosurg; 11(3): 216-20. https://doi.org/10.1080/02688699746276
Laurence DR, Bennett PN, MG Brown. Kidney and urinary tract. Clinical pharmacology. Eighth edition. Churchil Livingstone. Edinburgh London New York Philadelphia Sydney Toronto; 488.
Dorszewska J, Adamczewska-Goncerzewicz Z, Zukiel R, Nowak S, Moczko J. Lipid image in glioblastoma multiforme. Neurol Neurochir Pol 2000; 34(2): 321-7.
Brown RC, Cascio C, Papadopoulos V. Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J Neurochem 2000; 74(2): 847-59. https://doi.org/10.1046/j.1471-4159.2000.740847.x
Kaul D, Khosla VK. Molecular basis of cholesterol feedback lesion in CNS tumours. Neurol-India. 2000 Jun; 48(2): 174-7.
Giles GG, Gonzales MF. Epidemiology of brain tumours and factors in prognosis. In: Kaye AH and Laws ER. Jr (eds). Brain Tumours: An Encyclopedic Approach, 1st edition. Edinburgh Hong Kong London Madrid Melbourne New York Tokyo: Churchill Livingstone 1995: 47-67.
Preston-Martin S. A case-control study of brain tumours in men in Los Angeles County: investigation of N-nitroso compounds, tobaco smoke and mycotoxins. IARC Scientific Publications No 105. International Agency for Research on Cancer, Lyon 1990; 221-7.
Preston-Martin S, Henderson BE, Yu MC. Epidemiology of intracranial meningiomas: Los Angeles County, California. Neuroepidemiology 1984; 2: 164-78. https://doi.org/10.1159/000110522
Howe GR, Burch D, Chiarelli AM et al. An exploratory case-control study of brain tumours in children. Cancer Research 1989; 49: 4349-52.
Burch JD, Craib KJP, Choi BCK et al. An exploratory case-control study of brain cancers in adults. Journal of the National Cancer Institute 1987; 78: 601-9.
Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in men in Los Angeles County. Cancer Research 1989b; 49: 6137-43.
Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE. Risk factors for the tumours of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989; 8: 266-75.S. https://doi.org/10.1159/000110193
Boeing H, Schlehofer B, Bletiner M, Wahrendorf J. Dietary carcinogens and the risk for glioma and meningioma in Germany. International Journal of Cancer 1993; 53: 561-5. https://doi.org/10.1002/ijc.2910530406
Ryan P, Lee MW, North B, McMichael AJ. Risk factors for the tumours of the brain and meninges: results from the Adelaide adult brain tumour study. International Journal of Cancer 1992; 51:20-7. https://doi.org/10.1002/ijc.2910510105
Bunin GR, Kuijten RR, Boesel CP, Buckley JD, Meadows AT. Maternal diet and risk of astrocytic glioma in children: a report from the Childrens Cancer Group (United States and Canada) . Cancer Causes Control. 1994; 5(2): 177-87. https://doi.org/10.1007/BF01830264
El-Yazigi A, Al-Saleh I, Al-Mefty O. Concentrations of Ag, Al, Au, Bi, Cd, Cu, Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasms. Clin Chem. 1984; 30(8): 1358-60.
El-Yazigi A, Al-Saleh I, Al-Mefty O. Concentrations of zinc, iron, molybdenum, arsenic, and lithium in cerebrospinal fluid of patients with brain tumors. Clin Chem. 1986; 32(12): 2187-90.
El-Yazigi A, Martin CR, Siqueira EB. Concentrations of chromium, cesium, and tin in cerebrospinal fluid of patients with brain neoplasms, leukemia or other noncerebral malignancies, and neurological diseases. Clin Chem 1988; 34(6): 1084-6.
El-Yazigi A, Kanaan I, Martin CR, Siqueira EB. Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cerebral tumors, leukemia, and other noncerebral neoplasms. Oncology 1990; 47(5): 385-8. https://doi.org/10.1159/000226853
Jiang HM. Significance of measurement of serum and cerebrospinal fluid trace elements in the diagnosis of brain tumors. Chung Hua Chung Liu Tsa Chih. 1991; 13(3): 210-3.
Civit T, Houdayer A J, Kennedy G. A search for trace elements in some human intracranial tumors by instrumental neutron activation analysis. Biol Trace Elem Res. 2000; 74(3): 203-10. https://doi.org/10.1385/BTER:74:3:203
Mason JB. Consequences of altered micronutrient status. In: Goldman L, Bennett JC (eds). Cecil Textbook of Medicine, 21st edition. Philadelphia London Toronto Sydney: W. B. Saunders Company 2000: 1170-78.
Al-Rawi WWH, Hamad AWR, Hamash MH. "Trace elements profile among a group of patients with brain tumours". Iraqi Journal of Medical Sciences 2003; 2 suppl 1: 33-41.
Philipov P, Tzatchev K. Selenium concentrations in serum of patients with cerebral and extracerebral tumors. Zentralbl Neurochir 1988; 49(4): 344-7.
Zhang ZH,Kimura M, Itokawa Y. Inhibitory effect of selenium and change of glutathione peroxidase activity on rat glioma. Biol Trace Elem Res 1996; 55(1-2): 31-8. https://doi.org/10.1007/BF02784166
Zhu Z, Kimura M, Itokawa Y, Aoki T, Takahashi JA, Nakatsu S, Oda Y, Kikuchi H. Apoptosis induced by selenium in human glioma cell lines. Biol Trace Elem Res 1996; 54(2): 123-34. https://doi.org/10.1007/BF02786259
Sundaram N, Pahwa A K, Ard M D, Lin N, Perkins E, Bowles A P Jr. Selenium causes growth inhibition and apoptosis in human brain tumor cell lines. J Neurooncol 2000; 46(2): 125-33. https://doi.org/10.1023/A:1006436326003
Zhu Z, Kimura M, Itokawa Y, Nakatsu S, Oda Y, Kikuchi H. Effect of selenium on malignant tumor cells of brain. Biol Trace Elem Res 1995; 49(1): 1-7. https://doi.org/10.1007/BF02788998
Philipov P, Tzatchev K. Selenium in the treatment of patients with brain gliomas. A pilot study. Zentralbl Neurochir 1990; 51(3): 145-6.
Beljanski M, Crochet S. Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes. J Lab Clin Med 1994; 123(4): 547-55.
Sciaudone MP, Chattopadhyay S, Freake HC. Chelation of zinc amplifies induction of growth hormone mRNA levels in cultured rat pituitary tumor cells. J Nutr 2000; 130(2): 158-63. https://doi.org/10.1093/jn/130.2.158
Travaglini P, Mocchegiani E, De Min C, Re T, Fabris N, Faglia G. Zinc and bromocriptine long-term administration in patients with prolactinomas: effects on prolactin and thymulin circulating levels. Int-J-Neurosci. 1991 Jul; 59(1-3): 119-25. https://doi.org/10.3109/00207459108985454
Travaglini P, Mocchegiani E, Togni ME, Muratori M, Re T, Bazzoni N, Fabris N. Thymulin and zinc circulating levels in patients with GH and PRL secreting pituitary adenomas. Int-J-Neurosci 1990; 51(3-4): 269-71. https://doi.org/10.3109/00207459008999717
Rath FW, Enke H. Effect of orally administered zinc on the inducibility of experimental brain tumors in the rat. Arch Geschwulstforsch 1984; 54(3): 201-7.
Rem SS, Zagzag D, Tsanaclis AM, Gately S, Elkouby MP, Brien SE. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol 1990; 137(5): 1121-42.
Kaiser J, Gullotta F. Estimation of the copper content of astrocytomas and glioblastomas by the cuproin method. Neurochirurgia Stuttg 1980; 23(1): 20-3. https://doi.org/10.1055/s-2008-1053484
Brem S, Tsanaclis AM, Zagzag D. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Neurosurgery 1990; 26(3): 391-6. https://doi.org/10.1227/00006123-199003000-00003
Yoshida D, Ikeda Y, Nakazawa S. Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion. Neurol Med Chir Tokyo 1995; 35(3): 133-5. https://doi.org/10.2176/nmc.35.133
Yoshida D, Ikeda Y, Nakazawa S. Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model. Neurosurgery 1995; 37(2): 287-92; discussion 292-3. https://doi.org/10.1097/00006123-199508000-00014
Hadfield MG, Adera T, Smith B, Fortner Burton CA, Gibb RD, Mumaw V. Human brain tumors and exposure to metal and non-metal elements: a case-control study. J Environ Pathol Toxicol Oncol 1998; 17(1): 1-9.
Rao GM, Rao AV, Raja A, Rao S, Rao A. Role of antioxidant enzymes in brain tumours. Clin Chim Acta 2000; 296(1-2): 203-12. https://doi.org/10.1016/S0009-8981(00)00219-9
Turecky L, Kalina P, Uhlikova E, Namerova S, Krizko J. Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klin Wochenschr 1984; 62(4): 187-9. https://doi.org/10.1007/BF01731643
Kurisaka M. Mori K. Immunohistochemical study of medulloblastoma with a monoclonal antibody against human copper and zinc-superoxide dismutase. Neurol Med Chir Tokyo 1996; 36(4): 220-3. https://doi.org/10.2176/nmc.36.220
Downloads
Published
How to Cite
Issue
Section
Altmetrics
Downloads
License
All articles published in this scientific journal are protected by copyright. The authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits sharing the work with authorship recognition and without commercial purposes.
Readers may copy and distribute the material from this journal issue for non-commercial purposes in any medium, provided the original work is cited and credit is given to the authors and the journal.
Any commercial use of the material from this journal is strictly prohibited without written permission from the copyright holder.
For more information on the copyright of the journal and open access policies, please visit our website.